| 000 | 01617 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514060037.0 | ||
| 264 | 0 | _c20030728 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0143-4004 | ||
| 024 | 7 |
_a10.1053/plac.2002.0886 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoore, R M | |
| 245 | 0 | 0 |
_aPhysiological apoptotic agents have different effects upon human amnion epithelial and mesenchymal cells. _h[electronic resource] |
| 260 |
_bPlacenta _c |
||
| 300 |
_a173-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a8-Bromo Cyclic Adenosine Monophosphate _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmnion _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aDNA Fragmentation _xdrug effects |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEpithelial Cells _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
| 650 | 0 | 4 |
_aLactosylceramides _xpharmacology |
| 650 | 0 | 4 |
_aMesoderm _xdrug effects |
| 650 | 0 | 4 |
_aNitrobenzenes _xpharmacology |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aProstaglandin D2 _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aSilver, R J | |
| 700 | 1 | _aMoore, J J | |
| 773 | 0 |
_tPlacenta _gvol. 24 _gno. 2-3 _gp. 173-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/plac.2002.0886 _zAvailable from publisher's website |
| 999 |
_c12364558 _d12364558 |
||